Physician profile
Amanda Lam-Kellerman
NPI 1154191476
$317.63
in general payments reported to CMS, 2019-2025
10 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $177 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $69.45 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Novo Nordisk INC | $61.00 | 2024-2025 | Wegovy, Ozempic |
| Paratek Pharmaceuticals, INC. | $33.21 | 2025 | Nuzyra, Xhance |
| Hologic Sales and Service, LLC | $28.89 | 2024 | Thinprep 2000 Processor, Aptima |
| Sanofi-Aventis U.S. LLC | $25.92 | 2024 | |
| Verity Pharmaceuticals INC. | $25.46 | 2024 | Tlando |
| Exact Sciences Corporation | $20.71 | 2025 | Cologuard Collection Kit |
| Echosens North America, INC. | $19.11 | 2024 | Fibroscan |
| Seqirus USA INC | $17.41 | 2025 | Fluad, Flucelvax |
| Amgen INC. | $16.47 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lam-Kellerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.